AF
ABBV icon

Apexium Financial’s AbbVie ABBV Stock Holding History

Apexium Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.33M Buy
5,739
+141
+3% +$28.7K 0.06% 109
2025
Q2 		$1.04M Sell
5,598
-50
-0.9% -$9.29K 0.06% 125
2025
Q1 		$1.18M Buy
5,648
+1,680
+42% +$327K 0.07% 110
2024
Q4 		$705K Buy
3,968
+728
+22% +$134K 0.04% 134
2024
Q3 		$640K Buy
3,240
+663
+26% +$124K 0.04% 123
2024
Q2 		$442K Buy
2,577
+74
+3% +$12.3K 0.03% 145
2024
Q1 		$456K Sell
2,503
-183
-7% -$31.5K 0.03% 148
2023
Q4 		$416K Buy
2,686
+659
+33% +$96.1K 0.03% 189
2023
Q3 		$302K Buy
2,027
+37
+2% +$5.43K 0.03% 171
2023
Q2 		$268K Sell
1,990
-13
-0.6% -$1.91K 0.02% 186
2023
Q1 		$319K Sell
2,003
-24
-1% -$3.67K 0.03% 170
2022
Q4 		$328K Buy
2,027
+1
+0% +$153 0.03% 158
2022
Q3 		$272K Buy
+2,026
New +$291K 0.03% 161

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Apexium Financial's ABBV Position: Q3 2025 in Review

Apexium Financial increased its AbbVie (ABBV) stake by 2.5% in Q3 2025, buying an estimated $28.7K and bringing the position to 5,739 shares worth $1.33M. The position accounts for 0.06% of the portfolio, ranked #109.

Apexium Financial first reported a position in ABBV in Q3 2022 and has held it in 13 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Apexium Financial held 5,739 shares of AbbVie worth $1.33M as of Q3 2025.
  • Apexium Financial bought 141 AbbVie shares in Q3 2025, an estimated $28.7K.
  • AbbVie made up 0.06% of Apexium Financial's portfolio in Q3 2025, its #109 holding.
  • Apexium Financial first reported a position in AbbVie in Q3 2022 and has held it in 13 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Apexium Financial's 13F filing for Q3 2025, filed 18 Nov 2025.